Resistance risk asssement and molecular basis of metconazole in Fusarium pseudograminearum

Guixiang Li1, Yiwen Li1, Ling Zhang1

  • 1State Key Laboratory for Crop Stress Resistance and High-Efficiency Production, College of Plant Protection, Northwest A&F University, 3 Taicheng Road, Yangling, Shaanxi, 712100, China.

Stress Biology
|April 30, 2025
PubMed

Insights

Fusarium pseudograminearum shows low risk of developing resistance to the fungicide metconazole. Mutations in FpCYP51B genes, specifically M151T, and gene overexpression confer resistance, though mutants have reduced fitness.

Area of Science:

  • Agricultural Science
  • Mycology
  • Biochemistry

Background:

  • Metconazole, a sterol 14α-demethylation inhibitor (DMI) fungicide, effectively inhibits Fusarium pseudograminearum.
  • Understanding the resistance mechanisms and risk of F. pseudograminearum developing resistance to metconazole is crucial for effective disease management.

Purpose of the Study:

  • To assess the resistance risk of F. pseudograminearum to metconazole.
  • To identify the genetic and molecular mechanisms underlying metconazole resistance in F. pseudograminearum.

Main Methods:

  • Determined the EC50 of metconazole against F. pseudograminearum isolates.
  • Generated resistant mutants through fungicide adaptation and assessed their fitness.
  • Investigated cross-resistance with other DMI fungicides.
  • Identified mutations and gene expression changes in resistant mutants using molecular techniques.

Main Results:

  • Metconazole exhibited a low EC50 value (0.0559 μg/mL) against F. pseudograminearum.
  • Resistant mutants displayed reduced in vitro fitness.
  • Positive cross-resistance was observed with mefentrifluconazole and tebuconazole.
  • The M151T mutation in FpCYP51B and overexpression of FpCYP51 genes were identified as key resistance mechanisms.

Conclusions:

  • F. pseudograminearum has a low risk of developing resistance to metconazole due to reduced mutant fitness.
  • The M151T substitution in FpCYP51B and FpCYP51 gene overexpression confer metconazole resistance.
  • These findings provide insights into fungicide resistance management strategies for Fusarium diseases.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...